News & Events
FET FLAGSHIP Proposal on Personalized Health Care Initiative
More News
Integrating Biofabrication Technologies
Unlocking the secrets of osteochondral regeneration has long been a daunting challenge, with the intricate interplay between cartilage and bone presenting formidable hurdles. However, a groundbreaking approach is on the horizon, poised to redefine the landscape of tissue regeneration: multiphasic scaffolds – the cornerstone of cutting-edge strategies aimed at mirroring the complexities of the osteochondral unit and nurturing the growth of implanted bone-marrow derived stem cells (BMSCs). Yet, amidst the promise, hurdles remain. Stem cell loss during expansion in vitro and the limited control over their behavior within scaffolds both in vitro and in vivo pose formidable challenges.
Read More
Bioprinting in Space
In a new Pathfinder Open project, PULSE, we have partnered with different experts in space technology and use thereof to study how the Space environment could be working as an accelerator of ageing…
Read More
New Hybrid Biofabrication technology
Many tissues in our body display gradients. These are not only biological gradients, but also structural, physical, and chemical ones, resulting in smoother variations of mechanical properties and cell functional activity.
Read More
Kidney 3D in vitro models through bioprinting
At the Complex Tissue Regeneration department, we work hard to bridge the gap towards the dream of organs bioprinting. Step by step, we are now progressing towards understanding more and more in depth the requirements to bioprint different kidney cells, either derived from pluripotent stem cells or of adult species.
Read More
Bioprinting through Levitation
Magnetic levitation offers the possibility to place cells in a precise position in space through controlling the magnetic forces applied to magnetized cells. This new biofabrication technique, at the interface between bioprinting and bioassembly, provides new ways to create large-scale biological constructs that can be used for regenerative medicine purposes.
Read More
Published on: February 6, 2018
Category: Group Activities
The proposal is coordinated by the University of Minho, and is supported by a Steering Committee of 15 members, including Maastricht University, representing academia and industry leaders from across Europe. It is also supported by a large number of organisations, including over 140 academia and health institutes, 40 research institutes, 95 industry and associations and 25 regional and national authorities.
Through a multi-actor and multi-disciplinary approach, the initiative will focus on the development of targeted and specific therapies for diseases that have an impact on society and the patient, the development of new technologies, and preventive and predictive tools.
FET Flagships are one of the most prestigious, highly-funded, strongest and game-changing instruments of EU research. They will involve a total budget of about €1 billion including EU and public and private funding.
For more information and to show your support, please visit the Personalised Health Care Initiative website: http://web.spi.pt/fetflagship-personalisedhealthcare/
https://www.maastrichtuniversity.nl/news/um-partner-fet-flagship-proposal-personalised-health-care
